Skip to main content

Advertisement

Table 5 Secondary outcome measures for saint george's respiratory questionnaire (sgrq): Change of total symptom score, symptom score, activity score and impact score During 6 months of treatment with cineole or placebo*

From: Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial

SGRQ SCORES PLACEBO CINEOLE P VALUE †
  BASE LINE 6 MONTHS BASE LINE 6 MONTHS  
Symptom score 57.4 ± 20.2 48.5 ± 24.9 57.3 ± 20.4 43.8 ± 24.3 0.0224
Activity score 53.4 ± 21.9 50.0 ± 24.8 52.1 ± 20.5 43.5 ± 22.4 0.2032
Impact score 37.2 ± 20.9 33.9 ± 23.3 35.8 ± 20.2 27.4 ± 19.2 0.1126
TOTAL SYMPTOM SCORE 45.6 ± 18.9 41.3 ± 22.5 44.4 ± 17.8 34.5 ± 18.9 0.0630
  1. * Plus – minus values are means ± SD. Lower scores on the scores indicate higher quality of life.
  2. † P-Values are for the comparison of the changes in scores from base line to 6 months treatment between the two groups.